Myocarditis and Pericarditis After Vaccination for COVID-19

This study investigates the incidence of myocarditis and pericarditis emergency department or inpatient hospital encounters before COVID-19 vaccine availability (January 2019–January 2021) and during a COVID-19 vaccination period (February-May 2021) in a large US health care system.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2021-09, Vol.326 (12), p.1210-1212
Hauptverfasser:	Diaz, George A, Parsons, Guilford T, Gering, Sara K, Meier, Audrey R, Hutchinson, Ian V, Robicsek, Ari
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV Vaccine mRNA-1273 Ad26COVS1 Adult Aged BNT162 Vaccine Comments Confidence Intervals Coronaviruses COVID-19 COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - administration & dosage COVID-19 Vaccines - adverse effects Emergency medical care Emergency medical services Female Health care Heart diseases Hospitalization - statistics & numerical data Humans Immunization Incidence Letter Letters Los Angeles - epidemiology Male Middle Aged Montana - epidemiology Myocarditis Myocarditis - epidemiology Myocarditis - etiology Online First Oregon - epidemiology Pericarditis Pericarditis - epidemiology Pericarditis - etiology Poisson Distribution Research Letter Time Factors Vaccination Vaccines Washington - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This study investigates the incidence of myocarditis and pericarditis emergency department or inpatient hospital encounters before COVID-19 vaccine availability (January 2019–January 2021) and during a COVID-19 vaccination period (February-May 2021) in a large US health care system.
ISSN:	0098-7484 1538-3598
DOI:	10.1001/jama.2021.13443